ADHD – Benefits Canada.com https://www.benefitscanada.com Canada's most influential pension and benefits publication for decision-makers Fri, 03 May 2024 21:03:19 +0000 en-US hourly 1 https://wordpress.org/?v=4.9.8 Diabetes medications remain leading drug category for eligible claims in 2023: report https://www.benefitscanada.com/benefits/health-benefits/diabetes-medications-remain-leading-drug-category-for-eligible-claims-in-2023-report/ Wed, 24 Apr 2024 13:00:23 +0000 https://www.benefitscanada.com/?p=154574 In 2023, diabetes medications remained the leading drug category for eligible private insurance claims for the second consecutive year, according to Telus Health’s annual drug trends report. The report, based on claims data from more than 15 million plan members in 2023, found the growing prevalence of diabetes, along with expanded heart failure treatment indications and […]

The post Diabetes medications remain leading drug category for eligible claims in 2023: report appeared first on Benefits Canada.com.

]]> Expert panel: How employers can support neurodiverse workers through benefits, workplace policies https://www.benefitscanada.com/expertpanel_/kim-siddall/expert-panel-how-employers-can-support-neurodiverse-workers-through-benefits-workplace-policies/ Fri, 12 Apr 2024 13:00:15 +0000 https://www.benefitscanada.com/?p=154237 Canadian employers have taken important steps forward on a range of diversity, equity and inclusion matters. That work continues, particularly in the context of neurodiversity, which applies to an estimated 15 per cent to 20 per cent of the global population. Neurodiversity is a broad category that includes autism, attention-deficit hyperactivity disorder, dyslexia, Tourette’s syndrome, […]

The post Expert panel: How employers can support neurodiverse workers through benefits, workplace policies appeared first on Benefits Canada.com.

]]> How plan sponsors can improve employee health outcomes while optimizing drug plan spend https://www.benefitscanada.com/events/conference-coverage/how-plan-sponsors-can-improve-health-outcomes-while-optimizing-their-drug-plan-spend/ Mon, 22 Jan 2024 12:56:14 +0000 https://www.benefitscanada.com/?p=150572 With chronic conditions growing in prevalence among plan members, plan sponsors have their work cut out for them in designing benefits plans that provide adequate health support and employee satisfaction while also being cost effective, said Marie-Hélène Dugal, manager of pharmacy benefit strategy for Medavie Blue Cross, during Benefits Canada’s 2023 Face to Face Drug […]

The post How plan sponsors can improve employee health outcomes while optimizing drug plan spend appeared first on Benefits Canada.com.

]]> How employers can help employees with ADHD be engaged, productive https://www.benefitscanada.com/benefits/health-benefits/how-employers-can-help-employees-with-adhd-be-engaged-productive/ Tue, 12 Dec 2023 14:00:06 +0000 https://www.benefitscanada.com/?p=148649 With hybrid and remote working arrangements becoming increasingly common, employers can take an inclusive approach to help employees with attention deficit hyperactivity disorder feel more engaged and productive, says Dr. Marie-Hélène Geoffroy, a family medicine physician at the Cleveland Clinic Canada. “ADHD needs structure and remote working requires individuals to manage their own schedule and tasks, […]

The post How employers can help employees with ADHD be engaged, productive appeared first on Benefits Canada.com.

]]> 2023 BPS coverage: Diabetes, asthma, ADHD account for high drug claims in 2022 https://www.benefitscanada.com/events/conference-coverage/2023-bps-coverage-diabetes-asthma-adhd-account-for-high-drug-claims-in-2022/ Wed, 05 Jul 2023 11:56:30 +0000 https://www.benefitscanada.com/?p=140220 Three main drug categories — diabetes, asthma and stimulants for attention deficit hyperactivity disorder — accounted for rising drug claims in 2022, according to Lavina Viegas, Telus Health’s director of client account management, speaking during Benefits Canada‘s 2023 Benefits & Pension Summit in June. Referring to Telus Health’s 2023 drug plan trends report, she said […]

The post 2023 BPS coverage: Diabetes, asthma, ADHD account for high drug claims in 2022 appeared first on Benefits Canada.com.

]]> Specialty drugs accounting for smaller portion of total eligible claims amount: report https://www.benefitscanada.com/benefits/health-benefits/specialty-drugs-accounting-for-smaller-portion-of-total-eligible-claims-amount-report/ Wed, 14 Jun 2023 19:00:17 +0000 https://www.benefitscanada.com/?p=139815 Specialty drugs are accounting for a slightly smaller portion of the total eligible amount for all drug claims, declining from 33.6 per cent in 2021 to 33.1 per cent in 2022, according to Telus Health’s annual drug trends report. The report, based on claims data from more than 4.6 million plan members in 2022, found the […]

The post Specialty drugs accounting for smaller portion of total eligible claims amount: report appeared first on Benefits Canada.com.

]]> 2023 Drug Plan Trends Report: How the repercussions of the pandemic are trickling down to drug plans https://www.benefitscanada.com/archives_/benefits-canada-archive/2023-drug-plan-trends-report-how-the-repercussions-of-the-pandemic-are-trickling-down-to-drug-plans/ Fri, 17 Mar 2023 12:56:14 +0000 https://www.benefitscanada.com/?p=135012 As the coronavirus pandemic enters its fourth year, it’s perhaps unsurprising that the health crisis has taken its toll on employee mental health. Scotiabank saw a notable rise in claims for mental-health drugs in 2022, says Ayman Alvi, the bank’s vice-president of global pension and benefits, noting the increased use of these medications aligns with […]

The post 2023 Drug Plan Trends Report: How the repercussions of the pandemic are trickling down to drug plans appeared first on Benefits Canada.com.

]]> Taking a holistic approach to attention deficit hyperactivity disorder https://www.benefitscanada.com/events/conference-coverage/taking-a-holistic-approach-to-attention-deficit-hyperactivity-disorder/ Mon, 23 Jan 2023 12:57:11 +0000 https://www.benefitscanada.com/?p=132529 Attention deficit hyperactivity disorder is commonly misunderstood and can reduce the ability of a person to function while impacting their quality of life, said Anjila Arora, director of pharmaceutical benefits at Sun Life Financial Inc., during a session at Benefits Canada’s 2022 Face to Face Drug Plan Management Forum in Toronto in December. Although ADHD […]

The post Taking a holistic approach to attention deficit hyperactivity disorder appeared first on Benefits Canada.com.

]]>